Top Alzheimer’s Journals

4 min read
woman sitting on a wheelchair
First Published: 
Aug 2021
Jan 2024

Key Learnings contained in this article:

Need to get your hands on the latest research and perspectives in Alzheimer’s but not sure where to look? Well, we have done the legwork for you.

Here you will find the top 10 Alzheimer’s journals ranked by the 2-year Journal Impact Factor (2-JIF) – a measure of the frequency with which the articles within the journal are cited in a particular 2-year period. We have also included these other factors for each journal in our assessment to round off the picture.

Journal Metrics

Impact factor*

The Journal Impact Factor (JIF) is based on Web of Science data and only includes documents such as articles and reviews. The JIF helps to understand the importance of how often articles are cited by addressing the bias that arises from comparing citation numbers. This bias tends to advantage bigger journals over smaller ones, those published more often over those with fewer issues, and older journals over newer ones. This is because larger or older journals usually have more articles to be cited. By considering the impact factor, we can more fairly compare journals by taking into account these differences in size, publication frequency, and age. A JIF of 3 or more is considered good and 1 is average.


CiteScore is based on Scopus data for all indexed documents, including articles, letters and editorials, as well as articles and reviews. The CiteScore for a particular year is calculated by dividing the number of citations to all indexed documents within the journal from that year and the three preceding years by the total number of documents published in the journal within that same period.

*Impact factor and CiteScore have the most meaning when used to compare journals within the same therapeutic area. Many academics value a journal’s Impact Factor over its Citescore; therefore they will use the impact factor to rank other journals in the same field.

SCImago Journal Rank (SJR)

The SCImago Journal Rank (SJR) indicator evaluates the prestige of academic journals by considering not only the number of citations a journal receives but also the prestige of the journals that issue these citations. An SJR >1.0 is above average. This measurement can be helpful to rank journals within the same field and category.

Source Normalised Impact per Paper (SNIP)

Source Normalised Impact per Paper (SNIP) weights citations based on the total number of citations in a subject field to provide a contextual, subject-specific metric. A SNIP over 1.0 means a journal has more citations than average.

Other Journal considerations

In addition to SJR ranking and journal impact factor, a good quality journal generally has the following characteristics:

  1. It is indexed on PubMed, Google Scholar, Scopus, Web of Science or another reputable journal index.
  2. It has an up-to-date website, a clear scope, extensive information for authors and readers, and a publicly visible editorial board consisting of appropriately qualified board members affiliated with accredited universities and research institutions.
  3. Each article is assigned a Digital Object Identifier (DOI)

Top 10 Alzheimer’s Journals

Selecting the right journal for your research is a critical step that can make or break the impact of your work. This is where a medcomms agency like Rx Communications can become an essential ally. With a deep understanding of the scientific publishing world and high levels of therapeutic area expertise, a medcomms agency worth its salt should be able to provide support at any stage of the publishing process. This includes assisting in finding journals that match your research area and larger aims, and shaping your manuscript so it reflects the ethos and audience of your chosen journal, as well as guiding you through the entire submission process including managing revisions, and planning for post-publication promotion and dealing with rejection.

Rx can increase your chances of not just getting published, but also ensuring your research makes the waves it deserves.

Alzheimer's and Dementia

Alzheimer's & Dementia is the journal of the Alzheimer's Association. It aims to fill research gaps from basic science to clinical applications. It covers a range of topics including biochemistry, genetics, neurology, psychiatry, and more. The journal focuses on interdisciplinary studies about dementia's causes, early detection, prevention, and new health service technologies.

  • Website:
  • Impact Factor: 14.0
  • CiteScore: 14.7
  • SJR: 3.288
  • SNIP: 3.488
  • H-Index: 150

Alzheimer’s Research and Therapy

Alzheimer's Research and Therapy is an open access journal published by BioMed Central Ltd (BMC), a Springer Nature company. It offers a rich tapestry of content, delving into the latest research, groundbreaking clinical trials, innovative drug discovery, and in-depth epidemiological studies.

  • Website:
  • Impact Factor: 9.0
  • CiteScore: 12.0
  • SJR: 2.650
  • SNIP: 1.849
  • H-Index: 88

Journal of Prevention of Alzheimer's Disease (JPAD)

As a part of Springer Nature, JPAD aims to improve our knowledge in the field of Alzheimer’s prevention, covering topics including biomarkers, drug development, epidemiology, health economic outcomes, imaging, neuroscience, nutrition, physical cognitive exercise, public health, risk and protective factors, and trials design.

  • Website:
  • Impact Factor: 6.4
  • CiteScore: 7.8
  • SJR: 1.616
  • SNIP: 1.461
  • H-Index: 28

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring (DADM)

Another journal published by the Alzheimer's Association, DADM is an open access journal that publishes research on promising dementia biomarkers, aiming to improve early and accurate detection of Alzheimer's and dementia. Other topics published include development and validation of assays, instruments and technologies, as well as cognitive and functional markers of disease progression.

  • Website:
  • Impact Factor: 5.3
  • CiteScore: 8.4
  • SJR: 1.847
  • SNIP: 1.311
  • H-Index: 53

Alzheimer's and Dementia: Translational Research and Clinical Interventions (TRCI)

TRCI is an open access journal by the Alzheimer's Association. It aims to connect basic drug discovery research with clinical studies on aging-related brain conditions, including all forms of dementia including Alzheimer's disease. It focuses on translating research from various disciplines into practical applications for cognitive and motor function impairments, as well as other dementia symptoms.

  • Website:
  • Impact Factor: 4.8
  • CiteScore: 8.9
  • SJR: 1.800
  • SNIP: 1.558
  • H-Index: 49

Journal of Alzheimer's Disease

The Journal of Alzheimer’s Disease aims to advance knowledge in the origins, development, genetics, behavior, treatment, and psychology of Alzheimer's disease. It features various types of content including research reports, reviews, short communications, hypotheses, commentaries, editorials, and ethics reviews/responses, along with book reviews.

  • Website:
  • Impact Factor: 4.0
  • CiteScore: 6.4
  • SJR: 1.146
  • SNIP: 0.980
  • H-Index: 163

American Journal of Alzheimer's Disease and Other Dementias (AJADD)

AJADD is an open access journal that publishes original papers from professionals and researchers in Alzheimer's care, dementia, and clinical depression. It offers practical clinical information and the latest research on Alzheimer's. The journal discusses medical, psychiatric, and nursing challenges, including management of symptoms, communication difficulties, and pharmacotherapies.

  • Website:
  • Impact Factor: 3.4
  • CiteScore: 4.6
  • SJR: 0.696
  • SNIP: 0.786
  • H-Index: 69

Journal of Alzheimer's Disease Reports

The Journal of Alzheimer's Disease Reports is the open access sister journal to the Journal of Alzheimer’s Disease. JAD Reports aims to advance knowledge about the epidemiology, development, genetics, eitology, behavior, treatment, and psychological aspects of Alzheimer's disease.

  • Website:
  • Impact Factor: 3.2
  • CiteScore: 2.1
  • SJR: 0.578
  • SNIP: 0.629
  • H-Index: 9

Current Alzheimer Research

This journal publishes research covering the neurobiology, genetics, pathogenesis, diagnosis and treatment strategies of Alzheimer’s disease. It also covers research in molecular diagnostics, drug development and discovery, and brain imaging.

  • Website:
  • Impact Factor: 2.1
  • CiteScore: 5.1
  • SJR: 0.637
  • SNIP: 0.580
  • H-Index: 100

Alzheimer Disease and Associated Disorders

Alzheimer Disease & Associated Disorders focuses on Alzheimer's and related disorders. It publishes original research, clinical trials, reviews, and brief reports on epidemiology, diagnostics, and caregiver health, catering to clinicians and researchers.

  • Website:
  • Impact Factor: 2.1
  • CiteScore: 3.6
  • SJR: 0.676
  • SNIP: 0.855
  • H-Index: 105

Publish or Perish - as true now as it ever was

In the high-stakes world of pharma and biotech, "Publish or Perish" isn't just a catchy phrase—it's the stark reality. For pharma companies and researchers, it's not enough to develop breakthroughs; the real challenge lies in getting those findings recognised in top journals. In this game, it's not just about playing your cards right; it's about having a seasoned player on your team. With Rx Communications in your corner, you’ll be giving yourself the best chance to make an impact with your research. Explore our Publications Support Services here.

How to Stay Up-to-Date with Alzheimer's Research Developments

For pharma professionals and researchers working in the field of Alzheimer’s, it is vital to stay abreast of the latest research advancements. To stay on top you might:

  • Consider subscribing to our newsletter and receive updates to our top journal lists as well as other relevant industry and therapeutic developments as they happen.
  • Register for an account with your selected journal to get direct access to new research as it's published.
  • Customise an RSS feed for your selected journals to also further streamline the process, delivering the latest papers and articles directly to your digital doorstep.
  • Setting up a Google alert with Alzheimer's research keywords to capture relevant news and studies from across the web.
  • Lastly, don't underestimate the power of social media; by following the publishers and journals in the field, you'll tap into a community of shared knowledge and discourse.

* Article originally written by Sarah Cahill and published in 2021, updated by Beth Howe and the Rx Team for 2024!

We'll deliver straight to your inbox

We take your privacy very seriously and will never share your details with other parties.
You're subscribed! We'll send you a welcome email shortly, keep an eye out and if you don't find it perhaps check the (sometimes over-zealous) spam folder.
Oops! Something went wrong while submitting the form.
Beth Howe
Medical Writer
Bachelors in Biomedical Sciences, Bachelors in Biochemistry and Molecular Biology
Beth Howe is a passionate medical writer and member of the Australasian Medical Writers Association. With a degree from Victoria University of Wellington, she began her career during the COVID-19 pandemic, aiming to combat misinformation with factual scientific communication. Specialising in transforming complex research into accessible content, Beth's work spans from research manuscripts to informative health articles.
Share this post

Discover the Power of Communication with Rx

Embark on your medcomms journey with Rx today and experience the difference of working with a world-class medical communications agency.

Child playing in autumn leaves
Copyright Rx Communications Ltd